Stockscreener 앱 받기
25.55
2.14%
-0.56
시간 외 거래:
25.55
전일 마감가:
$26.11
열려 있는:
$25.851
하루 거래량:
10,159
Relative Volume:
0.25
시가총액:
$301.52M
수익:
$9.71M
순이익/손실:
$-29.96M
주가수익비율:
-7.342
EPS:
-3.48
순현금흐름:
$-14.79M
1주 성능:
-3.98%
1개월 성능:
-0.47%
6개월 성능:
+10.61%
1년 성능:
+25.68%
1일 변동 폭
$25.50
$25.86
1주일 범위
$24.80
$26.55
52주 변동 폭
$19.50
$35.00
Xoma Royalty Corp Stock (XOMA) Company Profile
명칭
Xoma Royalty Corp
전화
510-204-7239
주소
2200 POWELL STREET, EMERYVILLE, CA
XOMA을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
XOMA
Xoma Royalty Corp
|
25.55 | 301.52M | 9.71M | -29.96M | -14.79M | -3.48 |
|
VRTX
Vertex Pharmaceuticals Inc
|
469.32 | 122.13B | 10.63B | -479.80M | -1.35B | -1.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
710.00 | 78.30B | 14.20B | 4.41B | 3.54B | 38.28 |
|
ARGX
Argen X Se Adr
|
646.64 | 39.73B | 1.86B | -40.29M | -1.28B | -0.85 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
276.19 | 35.50B | 2.09B | -332.26M | 16.06M | -2.62 |
|
BNTX
Biontech Se Adr
|
117.61 | 28.47B | 3.30B | -501.07M | 1.03B | -2.1146 |
Xoma Royalty Corp Stock (XOMA) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-04-29 | 개시 | Leerink Partners | Outperform |
| 2021-09-07 | 다운그레이드 | Wedbush | Outperform → Neutral |
| 2021-06-29 | 개시 | Aegis Capital | Buy |
| 2021-01-19 | 재확인 | H.C. Wainwright | Buy |
| 2018-01-18 | 재확인 | H.C. Wainwright | Buy |
| 2017-10-17 | 재개 | H.C. Wainwright | Buy |
| 2017-09-05 | 업그레이드 | Wedbush | Neutral → Outperform |
| 2017-06-12 | 개시 | H.C. Wainwright | Buy |
| 2016-11-14 | 다운그레이드 | Wedbush | Outperform → Neutral |
| 2016-03-11 | 재확인 | Wedbush | Outperform |
| 2015-07-23 | 다운그레이드 | Jefferies | Buy → Hold |
| 2015-07-22 | 다운그레이드 | Ladenburg Thalmann | Buy → Neutral |
| 2015-07-22 | 다운그레이드 | Piper Jaffray | Overweight → Neutral |
| 2014-10-10 | 재개 | ROTH Capital | Buy |
| 2014-04-29 | 업그레이드 | MLV & Co | Hold → Buy |
| 2014-03-11 | 다운그레이드 | MLV & Co | Buy → Hold |
| 2014-03-05 | 재확인 | Ladenburg Thalmann | Buy |
| 2013-10-31 | 재확인 | MLV & Co | Buy |
| 2013-05-09 | 재확인 | Ladenburg Thalmann | Buy |
| 2012-05-14 | 개시 | Cowen & Co | Outperform |
| 2011-03-31 | 재확인 | MLV Capital | Buy |
| 2011-03-23 | 재확인 | RBC Capital Mkts | Outperform |
| 2011-01-06 | 재확인 | Ladenburg Thalmann | Buy |
| 2011-01-04 | 재확인 | Wedbush | Outperform |
모두보기
Xoma Royalty Corp 주식(XOMA)의 최신 뉴스
XOMA (NASDAQ:XOMA) Cut to Sell at StockNews.com - MarketBeat
HC Wainwright Issues Pessimistic Forecast for XOMA (NASDAQ:XOMA) Stock Price - MarketBeat
XOMA stock price target cut to $104 by H.C. Wainwright - MSN
HC Wainwright Has Lowered Expectations for XOMA (NASDAQ:XOMA) Stock Price - Defense World
StockNews.com Downgrades XOMA (NASDAQ:XOMA) to Sell - Defense World
XOMA Royalty to Present at Oppenheimer 35th Annual Healthcare Life Sciences Conference - GlobeNewswire
Exclusive Healthcare Insights: XOMA Leadership Takes Center Stage at Oppenheimer Conference - StockTitan
XOMA (NASDAQ:XOMAP) Trading Up 0.4% – Should You Buy? - Defense World
Forecasting The Future: 5 Analyst Projections For XOMA Royalty - Benzinga
XOMA Co. (NASDAQ:XOMA) Major Shareholder Bvf Partners L. P/Il Sells 500,742 Shares - MarketBeat
Short Interest in XOMA Co. (NASDAQ:XOMAO) Decreases By 34.2% - Defense World
Xoma royalty corp sees sale of $16.98 million in stock by investors - MSN
BIOTECHNOLOGY VALUE FUND L P Reduces Stake in XOMA Royalty Corp - GuruFocus.com
Xoma royalty corp sees sale of $16.98 million in stock by investors By Investing.com - Investing.com India
Barclays PLC Has $298,000 Stake in XOMA Co. (NASDAQ:XOMA) - Defense World
XOMA (NASDAQ:XOMA) Upgraded at StockNews.com - MarketBeat
XOMA (NASDAQ:XOMA) Stock Rating Upgraded by StockNews.com - Defense World
XOMA Royalty Corporation: High-Risk Royalty Aggregator Best Avoided - Seeking Alpha
XOMA (NASDAQ:XOMA) and Oragenics (NYSE:OGEN) Head to Head Review - Defense World
Xoma Royalty's chief investment officer buys $13,974 in stock By Investing.com - Investing.com Australia
XOMA (NASDAQ:XOMAP) Trading Down 0.8% – Here’s Why - Defense World
XOMA (NASDAQ:XOMA) Earns “Buy” Rating from HC Wainwright - Defense World
XOMA shares gain momentum, analyst notes 10%+ revenue growth potential from RZ358 - Investing.com
XOMA (NASDAQ:XOMA) Downgraded by StockNews.com to Sell - MarketBeat
HC Wainwright Reiterates "Buy" Rating for XOMA (NASDAQ:XOMA) - MarketBeat
Barclays PLC Acquires 8,447 Shares of XOMA Co. (NASDAQ:XOMA) - Defense World
Geode Capital Management LLC Purchases 1,138 Shares of XOMA Co. (NASDAQ:XOMA) - Defense World
State Street Corp Has $3.78 Million Holdings in XOMA Co. (NASDAQ:XOMA) - Defense World
Short Interest in XOMA Co. (NASDAQ:XOMAO) Grows By 26.7% - Defense World
XOMA Co. (NASDAQ:XOMA) Sees Significant Growth in Short Interest - Defense World
XOMA (NASDAQ:XOMA) Lowered to “Sell” Rating by StockNews.com - Defense World
XOMA (NASDAQ:XOMA) Lowered to "Sell" Rating by StockNews.com - MarketBeat
BNP Paribas Financial Markets Purchases 795 Shares of XOMA Co. (NASDAQ:XOMA) - Defense World
XOMA Royalty Declares Quarterly Preferred Stock Dividends - GlobeNewswire
XOMA Royalty Declares Quarterly Preferred Stock Dividends for Series A and B Shares - StockTitan
XOMA (NASDAQ:XOMA) Earns Buy Rating from HC Wainwright - Defense World
XOMA (NASDAQ:XOMAP) Trading Down 0.6% – Should You Sell? - Defense World
XOMA (NASDAQ:XOMA) Receives Buy Rating from HC Wainwright - MarketBeat
XOMA Co. (NASDAQ:XOMAO) Sees Significant Increase in Short Interest - Defense World
XOMA Co. (NASDAQ:XOMA) Shares Sold by Fmr LLC - MarketBeat
A Glimpse Into The Expert Outlook On XOMA Royalty Through 4 Analysts - Benzinga
XOMA shares target boosted, retains buy on new acquisition By Investing.com - Investing.com South Africa
XOMA Royalty’s Pulmokine brings seralutinib to pipeline - The Pharma Letter
XOMA shares target boosted, retains buy on new acquisition - Investing.com
Senti Bio’s Phase 1 CAR-NK data; Allink raises $42M - Endpoints News
Xoma Royalty acquires Pulmokine for $20M - TipRanks
XOMA Royalty Acquires Pulmokine for $20 Million Adding the Royalty and Milestone Interest in - The Bakersfield Californian
Xoma Royalty Corp (XOMA) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Xoma Royalty Corp 주식 (XOMA) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| BVF PARTNERS L P/IL | 10% Owner |
Jan 24 '25 |
Sale |
26.10 |
149,975 |
3,914,348 |
0 |
| Sitko Bradley | Chief Investment Officer |
Jan 08 '25 |
Buy |
25.60 |
313 |
8,013 |
313 |
| Sitko Bradley | Chief Investment Officer |
Jan 08 '25 |
Buy |
25.70 |
232 |
5,962 |
82 |
| Sitko Bradley | Chief Investment Officer |
Dec 31 '24 |
Buy |
25.90 |
300 |
7,770 |
9,150 |
| BURNS THOMAS M. | SVP, Finance & CFO |
Nov 11 '24 |
Option Exercise |
0.00 |
17,773 |
0 |
24,328 |
| BURNS THOMAS M. | SVP, Finance & CFO |
Nov 13 '24 |
Sale |
29.94 |
9,775 |
292,664 |
14,553 |
| Hughes Owen | Chief Executive Officer |
Nov 11 '24 |
Option Exercise |
0.00 |
53,360 |
0 |
56,860 |
| Hughes Owen | Chief Executive Officer |
Nov 13 '24 |
Sale |
29.95 |
21,881 |
655,336 |
34,979 |
1.09%
자본화:
|
볼륨(24시간):